A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell line. (2018)

First Author: Patrício MI
Attributed to:  Developing gene therapy to treat blindness caused by Stargardt Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.seizure.2017.12.005

PubMed Identifier: 29367144

Publication URI: http://europepmc.org/abstract/MED/29367144

Type: Journal Article/Review

Volume: 55

Parent Publication: Seizure

ISSN: 1059-1311